Iftikhar Afzal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iftikhar Afzal has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abdulhakeem S. Alamri
Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
1 shared publication - Amal F. Alshammary
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Anjum Khusheed
Department of Pharmacy, Grand Asian University, Sialkot, Pakistan
1 shared publication - Ayisha Khalid
Faculty of Pharmacy and Allied Health Sciences, University of Balochistan, Quetta 83700, Pakistan
1 shared publication - Hafiz Muhammad Mazhar Asjad
Department of Pharmacy Forman Christian College (A Chartered University) Lahore Pakistan
1 shared publication - Hammad Saleem
Institute of Pharmaceutical Sciences (IPS), University of Veterinary and Animal Sciences (UVAS), Lahore, Pakistan
1 shared publication
Latest Publications
- 23 October 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1595-1616
A Comprehensive Investigation of Dracaena Deremensis Extracts: Phytochemical Composition, Multi-Faceted Biochemical Propensities, ADMET and Computational Analysis
In this study, dichloromethane (DD-D) and methanolic (DD-M) extracts of Dracaena deremensis were comprehensively investigated for their phytochemical composition, antioxidant, antimicrobial, enzyme inhibition and computational properties. Preliminary phytochemical screening revealed the presence of various secondary metabolites, including alkaloids, flavonoids, phenols, steroids, cardiac glycosides and quinones. Quantitative analysis showed higher alkaloid content in both extracts, with DD-M (8.66 mg AE/g) slightly outperforming DD-D (7.61 mg AE/g). GC-MS profiling identified 54 compounds in DD-M and 48 in DD-D, representing diverse phytochemical classes. Both extracts exhibited strong antioxidant activity (DPPH, TAC, FRAP and NO assays) and notable antimicrobial effects against E. coli, S. typhi, K. pneumoniae, S. aureus and S. cerevisiae. Significant enzyme inhibition was observed against [ ]-glucosidase and tyrosinase, with moderate effects on AchE, BchE and LOX. Four key compounds, i.e. DC13, DC14, DC8 and MT16 demonstrated strong binding affinities in molecular docking simulations, supported by DFT-based HOMO-LUMO analysis and molecular dynamics studies, which confirmed stable binding conformations and favorable energetics. These results underscore D. deremensis as a promising source of multifunctional bioactive compounds, with potential applications in managing oxidative stress, microbial infections, neurodegeneration and metabolic disorders.
- 23 October 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1595-1616
A Comprehensive Investigation of Dracaena Deremensis Extracts: Phytochemical Composition, Multi-Faceted Biochemical Propensities, ADMET and Computational Analysis
In this study, dichloromethane (DD-D) and methanolic (DD-M) extracts of Dracaena deremensis were comprehensively investigated for their phytochemical composition, antioxidant, antimicrobial, enzyme inhibition and computational properties. Preliminary phytochemical screening revealed the presence of various secondary metabolites, including alkaloids, flavonoids, phenols, steroids, cardiac glycosides and quinones. Quantitative analysis showed higher alkaloid content in both extracts, with DD-M (8.66 mg AE/g) slightly outperforming DD-D (7.61 mg AE/g). GC-MS profiling identified 54 compounds in DD-M and 48 in DD-D, representing diverse phytochemical classes. Both extracts exhibited strong antioxidant activity (DPPH, TAC, FRAP and NO assays) and notable antimicrobial effects against E. coli, S. typhi, K. pneumoniae, S. aureus and S. cerevisiae. Significant enzyme inhibition was observed against [ ]-glucosidase and tyrosinase, with moderate effects on AchE, BchE and LOX. Four key compounds, i.e. DC13, DC14, DC8 and MT16 demonstrated strong binding affinities in molecular docking simulations, supported by DFT-based HOMO-LUMO analysis and molecular dynamics studies, which confirmed stable binding conformations and favorable energetics. These results underscore D. deremensis as a promising source of multifunctional bioactive compounds, with potential applications in managing oxidative stress, microbial infections, neurodegeneration and metabolic disorders.